Cancer vaccines: limited success but the research should remain viable

Expert Rev Vaccines. 2016 Jun;15(6):677-80. doi: 10.1586/14760584.2016.1145057. Epub 2016 Feb 9.

Authors

Constantin N Baxevanis¹, Sonia A Perez¹

Affiliation

¹ a Cancer Immunology and Immunotherapy Center , St Savas Cancer Hospital , Athens , Greece.

PMID: 26796430
DOI: 10.1586/14760584.2016.1145057

No abstract available

Publication types

Editorial

MeSH terms

Animals
Antineoplastic Agents, Immunological / adverse effects
Antineoplastic Agents, Immunological / therapeutic use*
Biomedical Research / methods*
Cancer Vaccines / adverse effects
Cancer Vaccines / immunology
Cancer Vaccines / therapeutic use*
Drug Discovery / methods*
Humans
Lymphocytes, Tumor-Infiltrating / immunology
Neoplasms / immunology
Neoplasms / pathology
Neoplasms / therapy*
Tumor Microenvironment

Substances

Antineoplastic Agents, Immunological
Cancer Vaccines